Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy MannKind Corporation (MNKD) shares
Learn how to easily invest in MannKind Corporation shares.
MannKind Corporation is a biotechnology business based in the US. MannKind Corporation stocks (MNKD.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $4.89 – a decrease of 3.32% over the previous week. MannKind Corporation employs 240 staff and has a trailing 12-month revenue of around $81.4 million.
How to buy shares in MannKind Corporation
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – MNKD – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
What's in this guide?
- Can I buy shares in MannKind Corporation?
- Has coronavirus impacted MannKind Corporation shares?
- MannKind Corporation shares summary
- Compare share dealing platforms
- Is MannKind Corporation stock a buy or sell?
- MannKind Corporation performance over time
- MannKind Corporation's financials
- How volatile are MannKind Corporation shares?
- Does MannKind Corporation pay a dividend?
- Have MannKind Corporation shares ever split?
- Other common questions
MannKind Corporation stock price (NASDAQ:MNKD)Use our graph to track the performance of MNKD stocks over time.
MannKind Corporation shares at a glance
|Latest market close||$3.79|
|52-week range||$3.12 - $6.25|
|50-day moving average||$4.43|
|200-day moving average||$4.47|
|Wall St. target price||$6.25|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-0.32|
Compare online stock trading platforms
Note: The dollar amounts in the table below are in Canadian dollars.
Is it a good time to buy MannKind Corporation stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
MannKind Corporation price performance over time
|1 week (2022-01-14)||-3.32%|
|1 month (2021-12-22)||-14.06%|
|3 months (2021-10-22)||-18.32%|
|6 months (2021-07-22)||-15.40%|
|1 year (2021-01-22)||7.06%|
|2 years (2020-01-22)||124.26%|
|3 years (2019-01-22)||170.71%|
|5 years (2017-01-20)||493.95%|
MannKind Corporation financials
|Revenue TTM||$81.4 million|
|Gross profit TTM||$40.5 million|
|Return on assets TTM||-12.77%|
|Return on equity TTM||0%|
|Market capitalisation||$984.9 million|
TTM: trailing 12 months
MannKind Corporation share dividends
We're not expecting MannKind Corporation to pay a dividend over the next 12 months.
Have MannKind Corporation's shares ever split?
MannKind Corporation's shares were split on a 1:5 basis on 2 March 2017. So if you had owned 5 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your MannKind Corporation shares – just the quantity. However, indirectly, the new 400% higher share price could have impacted the market appetite for MannKind Corporation shares which in turn could have impacted MannKind Corporation's share price.
MannKind Corporation share price volatility
Over the last 12 months, MannKind Corporation's shares have ranged in value from as little as $3.12 up to $6.25. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while MannKind Corporation's is 1.7547. This would suggest that MannKind Corporation's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
MannKind Corporation overview
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. The company offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity used for the treatment of hypothyroidism. The company has a license and collaboration agreement with United Therapeutics Corporation for the development and commercialization of a dry powder formulation of Treprostinil (Tyvaso DPI) used for the treatment of pulmonary arterial hypertension; and Thirona Bio to evaluate the therapeutic potential of TGF-ß inhibitor for the treatment of pulmonary fibrosis. It also has an agreement with NRx Pharmaceuticals to develop a dry powder formulation of ZYESAMI (aviptadil), a synthetic form of human vasoactive intestinal peptide to help protect cells against inflammatory conditions. MannKind Corporation was incorporated in 1991 and is headquartered in Westlake Village, California. .
MannKind Corporation in the news
Markets are expected to remain on edge as the Fed meets in the week ahead
Netflix quietly admits streaming competition is eating into growth
Microsoft's $68.7 billion deal for Activision once again shows big tech's dominance over legacy media
Frequently asked questions
More guides on Finder
How to buy Aritzia stock in Canada
Steps to owning and managing Aritzia (ATZ) stock, with 24-hour and historical pricing before you buy.
CI Direct Trading review
Get low fees and access many different types of accounts, platforms and investments with this reputable online broker.
Hifi Finance (MFT) price prediction
Read our expert analysis on Hifi Finance and how the token will perform in the future.
Kusama (KSM) price prediction
Read our expert analysis on Kusama and how the token will perform in the future.
How to buy The Sandbox (SAND) in Canada
This guide provides step-by-step instructions on how to buy The Sandbox, lists some exchanges where you can get it and provides daily price data on SAND.
COVID testing stocks
We’ve rounded up stats on some of the most popular COVID testing stocks, along with information on how they compare and how to invest.
Shiba Inu (SHIB) price, history and performance
This guide explores the different ways of buying Shiba Inu on a cryptocurrency exchange as well as where you should store your cryptocurrency.
Baby Doge Coin (BABYDOGE) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Baby Doge Coin, lists some exchanges where you can get it and provides daily price data on BABYDOGE.
Pendle (PENDLE) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Pendle, lists some exchanges where you can get it and provides daily price data on PENDLE.
Hempcoin (THC) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Hempcoin, lists some exchanges where you can get it and provides daily price data on THC.